{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:48:27Z","timestamp":1790743707330,"version":"4.1.0"},"reference-count":40,"publisher":"Scientific Scholar","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,1]]},"abstract":"\n Background & objectives:<\/jats:title>\n Sickle cell disease (SCD) patients require red cell transfusion during different clinical complications of the disease. Such patients are at a high risk for developing alloantibody against red cell antigens. From India, there are limited data available on alloantibody formation in multiply transfused SCD patients. The present study was thus undertaken to fill up this lacunae by looking at the development of red cell alloantibodies in SCD and \u03b2-thalassaemia patients on regular transfusion.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n All sickle cell disease patients undergoing red cell transfusion between 2008 and 2016, were included. During this period, a large number of \u03b2-thalassaemia major patients also underwent regular red cell transfusion. These thalassaemia patients were also included to compare the tendency of antibody formation between SCD and \u03b2-thalassaemia major patients. All patients before regular transfusion were regularly assessed for the development of red cell antibody. Red cell antigen, antibody screen crossmatch and antibody identification were done using the standard technique.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n A total of 138 patients with SCD aged between 4 and 53 yr (mean 17.6 yr) consisting of 83 males and 55 females (male:female, 1.5:1) along with 333 transfusion-dependent \u03b2-thalassaemia patients were studied. Over the last eight years, 15 patients with SCD and four patients with thalassaemia developed alloantibody (\n P<\/jats:italic>\n <0.001). Antibody specificity of their alloantibodies was against Rhc, RhE, Kell, Fy\n a<\/jats:sup>\n and Fy\n b<\/jats:sup>\n only. Sickle cell disease patients with and without alloantibody required on the average 11.8 and 8.6 units of red cell concentrate, respectively (\n P<\/jats:italic>\n <0.05).\n <\/jats:p>\n <\/jats:sec>\n \n Interpretation & conclusions:<\/jats:title>\n About 11 per cent of the transfused sickle cells patients developed alloantibodies. The antibody specificity was restricted to Rh, Kell and Duffy blood group systems. Extended antigen matching involving Rh, Kell and Duffy antigens may prevent alloantibody in such patients.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/ijmr.ijmr_940_17","type":"journal-article","created":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T01:51:35Z","timestamp":1555897895000},"page":"34-40","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":18,"title":["Comparative study of alloimmunization against red cell antigens in sickle cell disease & thalassaemia major patients on regular red cell transfusion"],"prefix":"10.25259","volume":"149","author":[{"given":"Keyuri","family":"Jariwala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanchan","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanjaksha","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"R1-6-20241212","first-page":"42","article-title":"Multiple red cell transfusions and alloimmunization. Experience with 6996 antibodies detected in a total of 159,262 patients from 1985 to 1993","volume":"119","author":"Hoeltge","year":"1995","journal-title":"Arch Pathol Lab Med"},{"key":"R2-6-20241212","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1182\/blood.V76.7.1431.1431","article-title":"Transfusion and alloimmunization in sickle cell disease. The cooperative study of sickle cell disease","volume":"76","author":"Rosse","year":"1990","journal-title":"Blood"},{"key":"R3-6-20241212","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1182\/blood-2011-11-327361","article-title":"Red blood cell alloimmunization in sickle cell disease: Pathophysiology, risk factors, and transfusion management","volume":"120","author":"Yazdanbakhsh","year":"2012","journal-title":"Blood"},{"key":"R4-6-20241212","first-page":"85","article-title":"Burden of thalassemia in India: The road map for control","volume":"2","author":"Colah","year":"2017","journal-title":"Pediatr Hematol Oncol J"},{"key":"R5-6-20241212","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4103\/0973-6247.187944","article-title":"A case of delayed hemolytic transfusion reaction in sickle cell disease patient","volume":"10","author":"Dogra","year":"2016","journal-title":"Asian J Transfus Sci"},{"key":"R6-6-20241212","first-page":"EC28","article-title":"Study of twenty one cases of red cell exchange in a tertiary care hospital in Southern India","volume":"10","author":"Daniel","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"R8-6-20241212","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1537-2995.2009.02435.x","article-title":"Red blood cell alloimmunizationin sickle cell disease patients in Uganda","volume":"50","author":"Natukunda","year":"2010","journal-title":"Transfusion"},{"key":"R9-6-20241212","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1046\/j.1537-2995.2002.00126.x","article-title":"Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: Theoretical and practical implications","volume":"42","author":"Castro","year":"2002","journal-title":"Transfusion"},{"key":"R10-6-20241212","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.26719\/2007.13.5.1181","article-title":"Red cell alloimmunization in sickle-cell anaemia patients","volume":"13","author":"Bashawri","year":"2007","journal-title":"East Mediterr Health J"},{"key":"R11-6-20241212","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1537-2995.1986.26386209381.x","article-title":"The incidence of development of irregular red cell antibodies in patients with sickle cell anemia","volume":"26","author":"Sarnaik","year":"1986","journal-title":"Transfusion"},{"key":"R12-6-20241212","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1111\/j.1537-2995.2009.02185.x","article-title":"Red blood cell alloimmunization among sickle cell Kuwaiti Arab patients who received red blood cell transfusion","volume":"49","author":"Ameen","year":"2009","journal-title":"Transfusion"},{"key":"R13-6-20241212","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1046\/j.1365-2141.2001.02819.x","article-title":"Red cell antibodies in patients with homozygous sickle cell disease: a comparison of patients in Jamaica and the United Kingdom","volume":"113","author":"Olujohungbe","year":"2001","journal-title":"Br J Haematol"},{"key":"R14-6-20241212","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJM199006073222301","article-title":"Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood","volume":"322","author":"Vichinsky","year":"1990","journal-title":"N Engl J Med"},{"key":"R15-6-20241212","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/(SICI)1096-8652(199607)52:3<197::AID-AJH11>3.0.CO;2-D","article-title":"Red blood cell alloimmunization in sickle cell disease: The influence of racial and antigenic pattern differences between donors and recipients in Brazil","volume":"52","author":"Moreira J\u00fanior","year":"1996","journal-title":"Am J Hematol"},{"key":"R16-6-20241212","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1537-2995.2002.00007.x","article-title":"Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions","volume":"42","author":"Aygun","year":"2002","journal-title":"Transfusion"},{"key":"R17-6-20241212","first-page":"7","article-title":"Evaluation of haemotherapy in thalassaemias (20 years of Indian experience)","volume":"90","author":"Jolly","year":"1992","journal-title":"J Indian Med Assoc"},{"key":"R18-6-20241212","first-page":"299","article-title":"Red cell alloimmunization in multi-transfused chronic renal failure patients undergoing hemodialysis","volume":"42","author":"Shukla","year":"1999","journal-title":"Indian J Pathol Microbiol"},{"key":"R19-6-20241212","first-page":"100","article-title":"Antibody to red cells in beta thalassemia major patients receiving multiple transfusion - A short report","volume":"19","author":"Pradhan","year":"2001","journal-title":"Indian J Haematol Blood Transfuse"},{"key":"R20-6-20241212","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1179\/102453308X343419","article-title":"Red cell alloimmunization in a transfused patient population: A study from a tertiary care hospital in North India","volume":"13","author":"Thakral","year":"2008","journal-title":"Hematology"},{"key":"R21-6-20241212","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1179\/102453309X12583347114013","article-title":"Alloimmunization and red cell autoimmunization in multitransfused thalassemics of Indian origin","volume":"15","author":"Pahuja","year":"2010","journal-title":"Hematology"},{"key":"R22-6-20241212","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.transci.2011.07.014","article-title":"Alloimmunization to red cells in thalassemics: Emerging problem and future strategies","volume":"45","author":"Gupta","year":"2011","journal-title":"Transfus Apher Sci"},{"key":"R23-6-20241212","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0377-1237(11)80008-0","article-title":"Red cell alloantibodies in multiple transfused thalassaemia patients","volume":"67","author":"Chaudhari","year":"2011","journal-title":"Med J Armed Forces India"},{"key":"R24-6-20241212","doi-asserted-by":"crossref","first-page":"378","DOI":"10.4103\/0377-4929.125295","article-title":"Red cell alloimmunization and infectious marker status (human immunodeficiency virus, hepatitis B virus and hepatitis C virus) in multiply transfused thalassemia patients of North India","volume":"56","author":"Makroo","year":"2013","journal-title":"Indian J Pathol Microbiol"},{"key":"R25-6-20241212","first-page":"401","article-title":"Antibody screening & Identification in the general patient population at a tertiary care hospital in New Delhi, India","volume":"140","author":"Makroo","year":"2014","journal-title":"Indian J Med Res"},{"key":"R26-6-20241212","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4103\/0973-6247.137438","article-title":"Alloimmunization and autoimmunization in transfusion dependent thalassemia major patients: Study on 319 patients","volume":"8","author":"Dhawan","year":"2014","journal-title":"Asian J Transfus Sci"},{"key":"R27-6-20241212","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s12288-013-0311-y","article-title":"Red blood cell antibodies in thalassemia patients in Northern India: Risk factors and literature review","volume":"30","author":"Elhence","year":"2014","journal-title":"Indian J Hematol Blood Transfus"},{"key":"R28-6-20241212","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12288-013-0282-z","article-title":"Detection and identification of red cell alloantibodies in multiply transfused thalassemia major patients: A prospective study","volume":"30","author":"Jain","year":"2014","journal-title":"Indian J Hematol Blood Transfus"},{"key":"R29-6-20241212","doi-asserted-by":"crossref","first-page":"610931","DOI":"10.1155\/2015\/610931","article-title":"Frequency of red cell alloimmunization and autoimmunization in thalassemia patients: A report from Eastern India","volume":"2015","author":"Datta","year":"2015","journal-title":"Adv Hematol"},{"key":"R30-6-20241212","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.transci.2015.02.019","article-title":"Red cell alloimmunisation in oncology patients: A study from Eastern India","volume":"52","author":"Dhar","year":"2015","journal-title":"Transfus Apher Sci"},{"key":"R31-6-20241212","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4103\/0973-6247.164268","article-title":"Direct antiglobulin test positivity in multi-transfused thalassemics","volume":"10","author":"Jain","year":"2016","journal-title":"Asian J Transfus Sci"},{"key":"R32-6-20241212","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s12098-013-1163-z","article-title":"Transfusion in sickle cell disease: Experience from a Gujarat centre","volume":"81","author":"Mehta","year":"2014","journal-title":"Indian J Pediatr"},{"key":"R33-6-20241212","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1159\/000369513","article-title":"Red blood cell alloimmunization in sickle cell disease: Listen to your ancestors","volume":"41","author":"Campbell-Lee","year":"2014","journal-title":"Transfus Med Hemother"},{"key":"R34-6-20241212","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1182\/blood-2013-03-490623","article-title":"High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors","volume":"122","author":"Chou","year":"2013","journal-title":"Blood"},{"key":"R35-6-20241212","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/ajh.24397","article-title":"Early occurrence of red blood cell alloimmunization in patients with sickle cell disease","volume":"91","author":"Sins","year":"2016","journal-title":"Am J Hematol"},{"key":"R36-6-20241212","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-2141.2005.05408.x","article-title":"Alloimmunization to red blood cell antigens after universal leucodepletion. A regional multicentre retrospective study","volume":"129","author":"Schonewille","year":"2005","journal-title":"Br J Haematol"},{"key":"R37-6-20241212","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/0090-1229(86)90136-4","article-title":"HLA-B35 is associated with red cell alloimmunization in sickle cell disease","volume":"38","author":"Alarif","year":"1986","journal-title":"Clin Immunol Immunopathol"},{"key":"R38-6-20241212","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1111\/trf.12624","article-title":"HLA-DRB1 associations in individuals with single and multiple clinically relevant red blood cell antibodies","volume":"54","author":"Schonewille","year":"2014","journal-title":"Transfusion"},{"key":"R39-6-20241212","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1182\/asheducation-2016.1.457","article-title":"Immunoregulatory networks in sickle cell alloimmunization","volume":"2016","author":"Yazdanbakhsh","year":"2016","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R40-6-20241212","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/vox.12086","article-title":"Red blood cell alloimmunization in sickle cell disease and in thalassaemia: Current status, future perspectives and potential role of molecular typing","volume":"106","author":"Matteocci","year":"2014","journal-title":"Vox Sang"},{"key":"R41-6-20241212","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/trf.13379","article-title":"Impact of red blood cell alloimmunization on sickle cell disease mortality: A case series","volume":"56","author":"Nickel","year":"2016","journal-title":"Transfusion"}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/02223309-201949010-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T19:01:04Z","timestamp":1751482864000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijmr.org.in\/comparative-study-of-alloimmunization-against-red-cell-antigens-in-sickle-cell-disease-thalassaemia-major-patients-on-regular-red-cell-transfusion\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmr.ijmr_940_17","relation":{},"ISSN":["0971-5916"],"issn-type":[{"value":"0971-5916","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}